We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Elasomeran (mRNA-1273)

Australian Public Assessment Report

AusPAR

AusPAR: Elasomeran (mRNA-1273) [PDF, 1.94 MB]

AusPAR: Elasomeran (mRNA-1273) [Word, 4.41 MB]

Attachment: Product Information for Elasomeran (mRNA-1273) [PDF, 398.62 KB]

Attachment: Product Information for Elasomeran (mRNA-1273) [Word, 874.9 KB]

Device/Product Name

Spikevax

Active ingredients

Elasomeran (mRNA-1273)

AusPAR Date

8 December 2021

Published

9 December 2021

Submission Number

PM-2021-05131-1-2

Submission Type

Major variation (change of dose regimen and patient group)

Decision

Approved for provisional registration